CC BY-NC-ND 4.0 · Laryngorhinootologie 2021; 100(S 02): S127-S128
DOI: 10.1055/s-0041-1727979
Abstracts
Head-Neck-Oncology: HPV / Tumor Marker

HPV-incidence and the role of p16INK4a expression in squamous cell carcinomas of the oropharynx

S Wagner
1   Klinik für HNO-Heilkunde, Kopf-/Halschirurgie Universitätsklinikum Gießen, Gießen
,
N Würdemann
1   Klinik für HNO-Heilkunde, Kopf-/Halschirurgie Universitätsklinikum Gießen, Gießen
,
C Langer
1   Klinik für HNO-Heilkunde, Kopf-/Halschirurgie Universitätsklinikum Gießen, Gießen
,
JP Klussmann
2   Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf-/Halschirurgie Universitätsklinikum Köln, Köln
,
C Wittekindt
1   Klinik für HNO-Heilkunde, Kopf-/Halschirurgie Universitätsklinikum Gießen, Gießen
› Author Affiliations
 
 

    INTRODUCTION Increasing incidence of head and neck cancer are reported worldwide, especially for oropharyngeal squamous cell carcinomas (OPSCC) induced by human papillomavirus (HPV). Due to a remarkably better prognosis, a de-escalation of the standard treatment for patients with HPV-driven OPSCC has been proposed. p16INK4a (p16) is currently accepted as a surrogate for HPV in OPSCC staging. However, the specificity rates have raised concerns about de-escalation when based solely on p16 expression, and experimental data on HPV prevalence in OPSCC are still insufficient.

    MATERIAL AND METHODS We investigated HPV-DNA status, p16 expression and multiple tumor- and patient-related risk factors in a consecutive cohort of OPSCC diagnosed between 2000 and 2017 and compared our data with cancer registry databases.

    RESULTS The HPV-attributable fraction comprises n=192 (27 % ) OPSCC with p16-expression and positivity for high-risk HPV-DNA, in most cases (95 % ) HPV-type 16. The incidence significantly increased in the oropharyngeal sub-sites tonsils and oropharynx, while others did not change. This is reflected in cancer registry data, although there are national differences. In n=39 OPSCC, p16-expression without detectable HPV DNA was found. According to principal component and survival analyses, 61 %  of these cases, which represented 11 %  of total p16-positive cases, were not comparable to HPV-driven OPSCC in terms of risk factor profile and overall survival.

    Discussion The increasing incidence of HPV-driven OPSCC is undeniable in several countries. Nevertheless, population-based studies of spatial heterogeneity and the role of HPV in subpopulations, such as p16-positive but HPV-DNA negative OPSCC, which appear unsuitable for treatment de-escalation, remain essential.

    Poster-PDF A-1476.pdf

    Teile dieser Arbeit wurde durch das Investigator Studies Program (MISP, Fördernummer: 56606) von MSD Sharp & Dohme GmbH unterstützt.


    #

    Conflict of interest

    Der Erstautor gibt keinen Interessenskonflikt an.

    Address for correspondence

    Dr. rer. nat. Wagner Steffen
    Klinik für HNO-Heilkunde, Kopf-/Halschirurgie Universitätsklinikum Gießen
    Gießen

    Publication History

    Article published online:
    13 May 2021

    © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany